SK282706B6 - Indolínové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukt - Google Patents

Indolínové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukt Download PDF

Info

Publication number
SK282706B6
SK282706B6 SK1752-98A SK175298A SK282706B6 SK 282706 B6 SK282706 B6 SK 282706B6 SK 175298 A SK175298 A SK 175298A SK 282706 B6 SK282706 B6 SK 282706B6
Authority
SK
Slovakia
Prior art keywords
mmol
solution
formula
indoline
compounds
Prior art date
Application number
SK1752-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK175298A3 (en
Inventor
Steven Mark Bromidge
Ian Thomson Forbes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK175298A3 publication Critical patent/SK175298A3/sk
Publication of SK282706B6 publication Critical patent/SK282706B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1752-98A 1996-06-20 1997-06-16 Indolínové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukt SK282706B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612883.0A GB9612883D0 (en) 1996-06-20 1996-06-20 Novel compounds
PCT/EP1997/003156 WO1997048699A1 (en) 1996-06-20 1997-06-16 Indoline derivatives useful as 5-ht-2c receptor antagonists

Publications (2)

Publication Number Publication Date
SK175298A3 SK175298A3 (en) 1999-05-07
SK282706B6 true SK282706B6 (sk) 2002-11-06

Family

ID=10795575

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1752-98A SK282706B6 (sk) 1996-06-20 1997-06-16 Indolínové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukt

Country Status (33)

Country Link
US (1) US6369060B1 (de)
EP (1) EP0912554B1 (de)
JP (1) JP2000512306A (de)
KR (1) KR20000022045A (de)
CN (1) CN1229408A (de)
AP (2) AP9801410A0 (de)
AR (1) AR008243A1 (de)
AT (1) ATE228514T1 (de)
AU (1) AU718597B2 (de)
BG (1) BG103089A (de)
BR (1) BR9709911A (de)
CA (1) CA2258240A1 (de)
CO (1) CO4890847A1 (de)
CZ (1) CZ420598A3 (de)
DE (1) DE69717449T2 (de)
DZ (1) DZ2250A1 (de)
EA (1) EA001780B1 (de)
ES (1) ES2187783T3 (de)
GB (1) GB9612883D0 (de)
HU (1) HUP9903439A3 (de)
ID (1) ID19433A (de)
IL (1) IL127417A0 (de)
MA (1) MA24214A1 (de)
NO (1) NO985972L (de)
NZ (1) NZ333229A (de)
OA (1) OA10944A (de)
PE (1) PE86698A1 (de)
PL (1) PL330796A1 (de)
SK (1) SK282706B6 (de)
TR (1) TR199802661T2 (de)
TW (1) TW382015B (de)
WO (1) WO1997048699A1 (de)
ZA (1) ZA975415B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3030899A (en) * 1998-02-25 1999-09-15 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
MXPA04005151A (es) 2001-11-28 2004-08-11 Upjohn Co Compuestos terapeuticos.
AU2003217817A1 (en) * 2002-03-04 2003-09-22 Pharmacia And Upjohn Company Pyridinyloxy derivatives as 5-ht receptor ligands
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
CA2749783A1 (en) 2009-01-16 2010-07-22 Massachusetts Institute Of Technology Diagnosis and treatment of autism spectrum disorders
WO2012080497A2 (en) 2010-12-17 2012-06-21 Glaxo Group Limited Methods of treatment and prevention of eye diseases
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
AU4704693A (en) * 1992-08-20 1994-03-15 Smithkline Beecham Plc Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
BR9607016A (pt) * 1995-02-02 1997-10-28 Smithkline Beecham Plc Derivados de indol como antagonísta de receptor 5-ht
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
PL330796A1 (en) 1999-06-07
WO1997048699A1 (en) 1997-12-24
AU3260297A (en) 1998-01-07
BG103089A (en) 1999-09-30
HUP9903439A2 (en) 2000-07-28
US6369060B1 (en) 2002-04-09
ATE228514T1 (de) 2002-12-15
BR9709911A (pt) 1999-08-10
CA2258240A1 (en) 1997-12-24
IL127417A0 (en) 1999-10-28
EA199900043A1 (ru) 1999-06-24
DE69717449T2 (de) 2003-10-02
ID19433A (id) 1998-07-09
DZ2250A1 (fr) 2002-12-18
CZ420598A3 (cs) 1999-06-16
NO985972D0 (no) 1998-12-18
AR008243A1 (es) 1999-12-29
AP745A (en) 1999-04-28
EP0912554A1 (de) 1999-05-06
AP9701037A0 (en) 1997-07-31
MA24214A1 (fr) 1997-12-31
EA001780B1 (ru) 2001-08-27
HUP9903439A3 (en) 2002-12-28
EP0912554B1 (de) 2002-11-27
CO4890847A1 (es) 2000-02-28
AP9801410A0 (en) 1998-12-31
KR20000022045A (ko) 2000-04-25
SK175298A3 (en) 1999-05-07
NO985972L (no) 1998-12-18
TW382015B (en) 2000-02-11
JP2000512306A (ja) 2000-09-19
AU718597B2 (en) 2000-04-20
GB9612883D0 (en) 1996-08-21
CN1229408A (zh) 1999-09-22
OA10944A (en) 2003-02-27
NZ333229A (de) 2000-01-28
DE69717449D1 (de) 2003-01-09
TR199802661T2 (xx) 1999-03-22
PE86698A1 (es) 1999-01-28
ES2187783T3 (es) 2003-06-16
ZA975415B (en) 1998-12-21

Similar Documents

Publication Publication Date Title
EP1448560B1 (de) 3-substituierte oxindol beta 3 agonisten
DE60217147T2 (de) Lactamderivate zur verwendung als humane 11cby rezeptorantagonisten
KR0174752B1 (ko) 이환식 헤테로환 함유 술폰아미드 유도체 및 그 제조방법
US5866586A (en) CNS-active pyridinylurea derivatives
WO1994014801A1 (en) Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
US20050090496A1 (en) Sulphonyl compounds with 5-ht6 receptor affinity
JP2002507611A (ja) イミダゾロン食欲抑制薬:ii.フェニル誘導体
WO1997008167A1 (en) 5ht2c and 5ht2b antagonists
US6313145B1 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
SK282706B6 (sk) Indolínové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukt
CA2841897A1 (en) Novel compound having parp inhibitory activity
WO1998052943A1 (en) Indoline derivatives as 5ht2c receptor antagonists
KR20000029564A (ko) 5HT2c길항제및D2길항제를함유하는약제학적조성물
KR100486795B1 (ko) 5-ht-2c수용체길항제로유용한인돌린유도체
SK137597A3 (en) 1-£'omega'-(3,4-dihydro-2-naphthalenyl)alkyl| cyclic amine derivatives, process for producing the same, and medicinal composition containing the same